Squamous cell carcinoma antigen: A role in the early identification of nodal metastases in men with squamous cell carcinoma of the penis

BJU International

Volumn 92, Issue 3, 2003, Pages 248-250

  Laniado, M E ^a   Lowdell, C ^a   Mitchell, H ^a   Christmas, T J ^a,b  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Carcinoma; Follow up; Penile neoplasms; Squamous cell; Tumour markers

Indexed keywords

SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER RISK; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MALE; PENIS CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PENILE NEOPLASMS; SENSITIVITY AND SPECIFICITY; SERPINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0041633493     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.04315.x     Document Type: Article

References (16)

1. Solsona E, Iborra I, Rubio J et al. Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. J Urol 2001; 165: 1506-9
2. Horenblas S. Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: the role and technique of lymph node dissection. BJU Int 2001; 88: 473-83
3. Horenblas S. Lymphadenectomy for squamous cell carcinoma of the penis. Part 1: diagnosis of lymph node metastasis. BJU Int 2001; 88: 467-72
4. Villavicencio H, Rubio-Briones J, Regalado R et al. Grade, local stage and growth pattern as prognostic factors in carcinoma of the penis. Eur Urol 1997; 32: 442-7
5. Maruo T, Yoshida S, Samoto T et al. Factors regulating SCC antigen expression in squamous cell carcinoma of the uterine cervix. Tumour Biol 1998; 19: 494-504
6. Bolger BS, Dabbas M, Lopes A, Monaghan JM. Prognostic value of preoperative squamous cell carcinoma antigen level in patients surgically treated for cervical carcinoma. Gynecol Oncol 1997; 65: 309-13
7. Indinnimeo M, Reale MG, Cicchini C et al. CEA, TPA, CA 19-9, SCC and CYFRA at diagnosis and in the follow-up of anal canal tumors. Int Surg 1997; 82: 275-9
8. Petrelli NJ, Palmer M, Herrera L, Bhargava A. The utility of squamous cell carcinoma antigen for the follow-up of patients with squamous cell carcinoma of the anal canal. Cancer 1992; 70: 35-9
9. Wishnow KI, Johnson DE, Fritsche H. Squamous cell carcinoma antigen (TA-4) in penile carcinoma. Urology 1990; 36: 315-7
10. Takahashi Y, Horie M, Isogai K et al. Clinical study of serum squamous cell carcinoma-related antigen levels in penile cancer. Hinyokika Kiyo 1987; 33: 396-9
11. Sobin LH, Wittekind C eds. Urological tumours. In TNM Classification of Urological Tumours. New York: Wiley-Liss, 1997: 165-94
12. Jaeschke R, Guyatt GH, Sackett DL. Users' guide to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994; 271: 703-7
13. Horenblas S, Jansen L, Meinhardt W et al. Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure. J Urol 2000; 163: 100-4
14. Akduman B, Fleshner NE, Ehrlich L, Klotz L. Early experience in intermediate-risk penile cancer with sentinel node identification using the gamma probe. Urology 2001; 58: 65-8
15. Ravizzini GC, Wagner M, Borges-Neto S. Positron emission tomography detection of metastatic penile squamous cell carcinoma. J Urol 2001; 165: 1633-4
16. Langen KJ, Borner AR, Muller-Mattheis V et al. Uptake of cis-4 and 8F-fluoro-L-proline in urologic tumors. J Nucl Med 2001; 42: 752-4